Tags

Type your tag names separated by a space and hit enter

Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology.
J Comp Neurol. 2013 Dec 15; 521(18):4236-48.JC

Abstract

Early observations of the patterns of neurofibrillary tangles and amyloid plaques in Alzheimer's disease suggested a hierarchical vulnerability of neurons for tangles, and a widespread nonspecific pattern of plaques that nonetheless seemed to correlate with the terminal zone of tangle-bearing neurons in some instances. The first neurofibrillary cortical lesions in Alzheimer's disease occur in the entorhinal cortex, thereby disrupting the origin of the perforant pathway projection to the hippocampus, and amyloid deposits are often found in the molecular layer of the dentate gyrus, which is the terminal zone of the entorhinal cortex. We modeled these anatomical changes in a transgenic mouse model that overexpresses both P301L tau (uniquely in the medial entorhinal cortex) and mutant APP/PS1 (in a widespread distribution) to examine the anatomical consequences of early tangles, plaques, or the combination. We find that tau uniformly occupies the terminal zone of the perforant pathway in tau-expressing mice. By contrast, the addition of amyloid deposits in this area leads to disruption of the perforant pathway terminal zone and apparent aberrant distribution of tau-containing axons. Moreover, human P301L tau-containing axons appear to increase the extent of dystrophic axons around plaques. Thus, the presence of amyloid deposits in the axonal terminal zone of pathological tau-containing neurons profoundly impacts their normal connectivity.

Authors+Show Affiliations

King's College London, Institute of Psychiatry, Department of Neuroscience, London, SE5 8AF, UK; Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, 02129, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23839581

Citation

Pooler, Amy M., et al. "Tau-amyloid Interactions in the rTgTauEC Model of Early Alzheimer's Disease Suggest Amyloid-induced Disruption of Axonal Projections and Exacerbated Axonal Pathology." The Journal of Comparative Neurology, vol. 521, no. 18, 2013, pp. 4236-48.
Pooler AM, Polydoro M, Wegmann SK, et al. Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology. J Comp Neurol. 2013;521(18):4236-48.
Pooler, A. M., Polydoro, M., Wegmann, S. K., Pitstick, R., Kay, K. R., Sanchez, L., Carlson, G. A., Gomez-Isla, T., Albers, M. W., Spires-Jones, T. L., & Hyman, B. T. (2013). Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology. The Journal of Comparative Neurology, 521(18), 4236-48. https://doi.org/10.1002/cne.23411
Pooler AM, et al. Tau-amyloid Interactions in the rTgTauEC Model of Early Alzheimer's Disease Suggest Amyloid-induced Disruption of Axonal Projections and Exacerbated Axonal Pathology. J Comp Neurol. 2013 Dec 15;521(18):4236-48. PubMed PMID: 23839581.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology. AU - Pooler,Amy M, AU - Polydoro,Manuela, AU - Wegmann,Susanne K, AU - Pitstick,Rose, AU - Kay,Kevin R, AU - Sanchez,Laura, AU - Carlson,George A, AU - Gomez-Isla,Teresa, AU - Albers,Mark W, AU - Spires-Jones,Tara L, AU - Hyman,Bradley T, PY - 2013/03/09/received PY - 2013/05/02/revised PY - 2013/06/28/accepted PY - 2013/7/11/entrez PY - 2013/7/11/pubmed PY - 2014/6/12/medline KW - Alzheimer's disease KW - Van Hoesen KW - perforant pathway SP - 4236 EP - 48 JF - The Journal of comparative neurology JO - J Comp Neurol VL - 521 IS - 18 N2 - Early observations of the patterns of neurofibrillary tangles and amyloid plaques in Alzheimer's disease suggested a hierarchical vulnerability of neurons for tangles, and a widespread nonspecific pattern of plaques that nonetheless seemed to correlate with the terminal zone of tangle-bearing neurons in some instances. The first neurofibrillary cortical lesions in Alzheimer's disease occur in the entorhinal cortex, thereby disrupting the origin of the perforant pathway projection to the hippocampus, and amyloid deposits are often found in the molecular layer of the dentate gyrus, which is the terminal zone of the entorhinal cortex. We modeled these anatomical changes in a transgenic mouse model that overexpresses both P301L tau (uniquely in the medial entorhinal cortex) and mutant APP/PS1 (in a widespread distribution) to examine the anatomical consequences of early tangles, plaques, or the combination. We find that tau uniformly occupies the terminal zone of the perforant pathway in tau-expressing mice. By contrast, the addition of amyloid deposits in this area leads to disruption of the perforant pathway terminal zone and apparent aberrant distribution of tau-containing axons. Moreover, human P301L tau-containing axons appear to increase the extent of dystrophic axons around plaques. Thus, the presence of amyloid deposits in the axonal terminal zone of pathological tau-containing neurons profoundly impacts their normal connectivity. SN - 1096-9861 UR - https://www.unboundmedicine.com/medline/citation/23839581/Tau_amyloid_interactions_in_the_rTgTauEC_model_of_early_Alzheimer's_disease_suggest_amyloid_induced_disruption_of_axonal_projections_and_exacerbated_axonal_pathology_ L2 - https://doi.org/10.1002/cne.23411 DB - PRIME DP - Unbound Medicine ER -